CellaVision AB
OTC:CLVSF
Relative Value
The Relative Value of one CLVSF stock under the Base Case scenario is 30.24 USD. Compared to the current market price of 20.24 USD, CellaVision AB is Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
CLVSF Competitors Multiples
CellaVision AB Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
SE |
CellaVision AB
OTC:CLVSF
|
5.4B USD | 8 | 41.6 | 25.8 | 31.9 | ||
US |
Abbott Laboratories
NYSE:ABT
|
182.6B USD | 4.5 | 32.4 | 19.1 | 28.5 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
132.5B USD | 18.1 | 66.7 | 54.7 | 68.5 | ||
US |
Stryker Corp
NYSE:SYK
|
123.5B USD | 5.9 | 36.7 | 23.9 | 29.4 | ||
IE |
Medtronic PLC
NYSE:MDT
|
107.2B USD | 3.3 | 25.5 | 13.6 | 19.3 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
104.5B USD | 7.1 | 59.2 | 30.2 | 44.6 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.6B USD | 3.5 | 55.5 | 18.6 | 39.3 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.2B EUR | 2.6 | 37.7 | 18.2 | 30.6 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.1B USD | 8.3 | 36.1 | 26.2 | 28.4 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50B USD | 13.1 | 78.2 | 58.4 | 76.1 |